| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 305.4K | $2.55M | - | |
| CFO | 215.4K | $1.80M | - | |
| Dir | 119.9K | $999.6K | - | |
| VP | 104.1K | $868.3K | - | |
| Dir | 89.0K | $742.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2020 | El-Hibri Fuad | Chairman | Sell | 40,000 | $102.73 | $4,109,200.00 | -1.6% | |
| Sep 2, 2020 | Sullivan Louis W62 | Director | Sale+OE | 28,418 | $111.22 | $3,160,605.90 | -24.9% | |
| Aug 18, 2020 | Bailey Sue | Director | Sell | 4,665 | $128.31 | $598,563.82 | -12.5% | |
| Aug 17, 2020 | Harsanyi Zsolt | Director | Sell | 6,609 | $133.71 | $883,664.28 | -21.2% | |
| Aug 11, 2020 | Joulwan George A | Director | Sell | 6,000 | $124.11 | $744,635.40 | -18.3% | |
| Aug 10, 2020 | Zoon Kathryn C62 | Director | Sell | 1,000 | $130.27 | $130,270.00 | -7.4% | |
| Aug 7, 2020 | Richard Ronald | Director | Sell | 6,297 | $131.00 | $824,907.00 | -43.2% | |
| Jun 3, 2020 | Richard Ronald | Director | Sell | 6,572 | $87.51 | $575,142.01 | -60.6% | |
| Jun 3, 2020 | Bailey Sue | Director | Sell | 5,322 | $87.50 | $465,690.97 | -12.5% | |
| May 26, 2020 | Hauer Jerome M | Director | Sell | 4,385 | $85.15 | $373,373.10 | -30.1% |